Enveric Biosciences , a cutting-edge neuroscience company developing next-generation, psychedelic-inspired mental health medicines, is working with the University of Calgary's Hotchkiss Brain Institute ("HBI"),...
Cambrian Biopharma, a multi-asset longevity biotech, announced a licensing agreement with Novartis to advance novel, selective compounds designed and characterized by Novartis to target...
Curve Therapeutics (Curve), a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, announces a global research collaboration with MSD, the trade...
